Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy

Edecio Cunha-Neto, Victor J. Dzau, Paul D. Allen, Dimitri Stamatiou, Luiz Benvenutti, M. Lourdes Higuchi, Natalia S. Koyama, Joao S. Silva, Jorge Kalil, Choong Chin Liew

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Chronic Chagas' disease cardiomyopathy is a leading cause of congestive heart failure in Latin America, affecting more than 3 million people. Chagas' cardiomyopathy is more aggressive than other cardiomyopathies, but little is known of the molecular mechanisms responsible for its severity. We characterized gene expression profiles of human Chagas' cardiomyopathy and dilated cardiomyopathy to identify selective disease pathways and potential therapeutic targets. Both our customized cDNA microarray (Cardiochip) and real-time reverse transcriptase-polymerase chain reaction analysis showed that immune response, lipid metabolism, and mitochondrial oxidative phosphorylation genes were selectively up-regulated in myocardial tissue of the tested Chagas' cardiomyopathy patients. Interferon (IFN)-γ-inducible genes represented 15% of genes specifically up-regulated in Chagas' cardiomyopathy myocardial tissue, indicating the importance of IFN-γ signaling. To assess whether IFN-γ can directly modulate cardiomyocyte gene expression, we exposed fetal murine cardiomyocytes to IFN-γ and the IFN-γ-inducible chemokine monocyte chemoattractant protein-1. Atrial natriuretic factor expression increased 15-fold in response to IFN-γ whereas combined IFN-γ and monocyte chemoattractant protein-1 increased atrial natriuretic factor expression 400-fold. Our results suggest IFN-γ and chemokine signaling may directly up-regulate cardiomyocyte expression of genes involved in pathological hypertrophy, which may lead to heart failure. IFN-γ and other cytokine pathways may thus be novel therapeutic targets in Chagas' cardiomyopathy.

Original languageEnglish (US)
Pages (from-to)305-313
Number of pages9
JournalAmerican Journal of Pathology
Volume167
Issue number2
StatePublished - Aug 2005
Externally publishedYes

Fingerprint

Chagas Cardiomyopathy
Chagas Disease
Gene Expression Profiling
Interferons
Cardiac Myocytes
Chemokine CCL2
Atrial Natriuretic Factor
Chemokines
Heart Failure
Genes
Gene Expression
Latin America
Oxidative Phosphorylation
Dilated Cardiomyopathy
Oligonucleotide Array Sequence Analysis
Reverse Transcriptase Polymerase Chain Reaction
Cardiomyopathies
Lipid Metabolism
Transcriptome
Hypertrophy

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Cunha-Neto, E., Dzau, V. J., Allen, P. D., Stamatiou, D., Benvenutti, L., Higuchi, M. L., ... Liew, C. C. (2005). Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. American Journal of Pathology, 167(2), 305-313.

Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. / Cunha-Neto, Edecio; Dzau, Victor J.; Allen, Paul D.; Stamatiou, Dimitri; Benvenutti, Luiz; Higuchi, M. Lourdes; Koyama, Natalia S.; Silva, Joao S.; Kalil, Jorge; Liew, Choong Chin.

In: American Journal of Pathology, Vol. 167, No. 2, 08.2005, p. 305-313.

Research output: Contribution to journalArticle

Cunha-Neto, E, Dzau, VJ, Allen, PD, Stamatiou, D, Benvenutti, L, Higuchi, ML, Koyama, NS, Silva, JS, Kalil, J & Liew, CC 2005, 'Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy', American Journal of Pathology, vol. 167, no. 2, pp. 305-313.
Cunha-Neto E, Dzau VJ, Allen PD, Stamatiou D, Benvenutti L, Higuchi ML et al. Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. American Journal of Pathology. 2005 Aug;167(2):305-313.
Cunha-Neto, Edecio ; Dzau, Victor J. ; Allen, Paul D. ; Stamatiou, Dimitri ; Benvenutti, Luiz ; Higuchi, M. Lourdes ; Koyama, Natalia S. ; Silva, Joao S. ; Kalil, Jorge ; Liew, Choong Chin. / Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. In: American Journal of Pathology. 2005 ; Vol. 167, No. 2. pp. 305-313.
@article{2202494e57a3436380692e28b7381f1c,
title = "Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy",
abstract = "Chronic Chagas' disease cardiomyopathy is a leading cause of congestive heart failure in Latin America, affecting more than 3 million people. Chagas' cardiomyopathy is more aggressive than other cardiomyopathies, but little is known of the molecular mechanisms responsible for its severity. We characterized gene expression profiles of human Chagas' cardiomyopathy and dilated cardiomyopathy to identify selective disease pathways and potential therapeutic targets. Both our customized cDNA microarray (Cardiochip) and real-time reverse transcriptase-polymerase chain reaction analysis showed that immune response, lipid metabolism, and mitochondrial oxidative phosphorylation genes were selectively up-regulated in myocardial tissue of the tested Chagas' cardiomyopathy patients. Interferon (IFN)-γ-inducible genes represented 15{\%} of genes specifically up-regulated in Chagas' cardiomyopathy myocardial tissue, indicating the importance of IFN-γ signaling. To assess whether IFN-γ can directly modulate cardiomyocyte gene expression, we exposed fetal murine cardiomyocytes to IFN-γ and the IFN-γ-inducible chemokine monocyte chemoattractant protein-1. Atrial natriuretic factor expression increased 15-fold in response to IFN-γ whereas combined IFN-γ and monocyte chemoattractant protein-1 increased atrial natriuretic factor expression 400-fold. Our results suggest IFN-γ and chemokine signaling may directly up-regulate cardiomyocyte expression of genes involved in pathological hypertrophy, which may lead to heart failure. IFN-γ and other cytokine pathways may thus be novel therapeutic targets in Chagas' cardiomyopathy.",
author = "Edecio Cunha-Neto and Dzau, {Victor J.} and Allen, {Paul D.} and Dimitri Stamatiou and Luiz Benvenutti and Higuchi, {M. Lourdes} and Koyama, {Natalia S.} and Silva, {Joao S.} and Jorge Kalil and Liew, {Choong Chin}",
year = "2005",
month = "8",
language = "English (US)",
volume = "167",
pages = "305--313",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy

AU - Cunha-Neto, Edecio

AU - Dzau, Victor J.

AU - Allen, Paul D.

AU - Stamatiou, Dimitri

AU - Benvenutti, Luiz

AU - Higuchi, M. Lourdes

AU - Koyama, Natalia S.

AU - Silva, Joao S.

AU - Kalil, Jorge

AU - Liew, Choong Chin

PY - 2005/8

Y1 - 2005/8

N2 - Chronic Chagas' disease cardiomyopathy is a leading cause of congestive heart failure in Latin America, affecting more than 3 million people. Chagas' cardiomyopathy is more aggressive than other cardiomyopathies, but little is known of the molecular mechanisms responsible for its severity. We characterized gene expression profiles of human Chagas' cardiomyopathy and dilated cardiomyopathy to identify selective disease pathways and potential therapeutic targets. Both our customized cDNA microarray (Cardiochip) and real-time reverse transcriptase-polymerase chain reaction analysis showed that immune response, lipid metabolism, and mitochondrial oxidative phosphorylation genes were selectively up-regulated in myocardial tissue of the tested Chagas' cardiomyopathy patients. Interferon (IFN)-γ-inducible genes represented 15% of genes specifically up-regulated in Chagas' cardiomyopathy myocardial tissue, indicating the importance of IFN-γ signaling. To assess whether IFN-γ can directly modulate cardiomyocyte gene expression, we exposed fetal murine cardiomyocytes to IFN-γ and the IFN-γ-inducible chemokine monocyte chemoattractant protein-1. Atrial natriuretic factor expression increased 15-fold in response to IFN-γ whereas combined IFN-γ and monocyte chemoattractant protein-1 increased atrial natriuretic factor expression 400-fold. Our results suggest IFN-γ and chemokine signaling may directly up-regulate cardiomyocyte expression of genes involved in pathological hypertrophy, which may lead to heart failure. IFN-γ and other cytokine pathways may thus be novel therapeutic targets in Chagas' cardiomyopathy.

AB - Chronic Chagas' disease cardiomyopathy is a leading cause of congestive heart failure in Latin America, affecting more than 3 million people. Chagas' cardiomyopathy is more aggressive than other cardiomyopathies, but little is known of the molecular mechanisms responsible for its severity. We characterized gene expression profiles of human Chagas' cardiomyopathy and dilated cardiomyopathy to identify selective disease pathways and potential therapeutic targets. Both our customized cDNA microarray (Cardiochip) and real-time reverse transcriptase-polymerase chain reaction analysis showed that immune response, lipid metabolism, and mitochondrial oxidative phosphorylation genes were selectively up-regulated in myocardial tissue of the tested Chagas' cardiomyopathy patients. Interferon (IFN)-γ-inducible genes represented 15% of genes specifically up-regulated in Chagas' cardiomyopathy myocardial tissue, indicating the importance of IFN-γ signaling. To assess whether IFN-γ can directly modulate cardiomyocyte gene expression, we exposed fetal murine cardiomyocytes to IFN-γ and the IFN-γ-inducible chemokine monocyte chemoattractant protein-1. Atrial natriuretic factor expression increased 15-fold in response to IFN-γ whereas combined IFN-γ and monocyte chemoattractant protein-1 increased atrial natriuretic factor expression 400-fold. Our results suggest IFN-γ and chemokine signaling may directly up-regulate cardiomyocyte expression of genes involved in pathological hypertrophy, which may lead to heart failure. IFN-γ and other cytokine pathways may thus be novel therapeutic targets in Chagas' cardiomyopathy.

UR - http://www.scopus.com/inward/record.url?scp=25144458663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25144458663&partnerID=8YFLogxK

M3 - Article

VL - 167

SP - 305

EP - 313

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 2

ER -